A 14-gene assay predicts chemotherapy benefit in early-stage non-small-cell lung cancer, improving 24-month disease-free ...

A study shows for the first time the relationship between this disease and the damage caused to DNA by breathing pollution.

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...